Recent GLAD News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 09:32:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/05/2024 09:28:08 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/05/2024 09:02:56 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 02/02/2024 01:45:25 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 02/01/2024 04:12:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/24/2024 09:08:56 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 01/18/2024 05:15:11 AM
- Form N-2/A - Registration statement for closed-end investment companies: [Amend] • Edgar (US Regulatory) • 01/12/2024 09:22:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/09/2024 09:13:34 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 01/05/2024 09:16:27 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 01/04/2024 09:19:30 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 12/20/2023 09:06:57 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/13/2023 10:24:45 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 12/11/2023 05:07:27 PM
- Form N-2 - Registration statement for closed-end investment companies • Edgar (US Regulatory) • 12/07/2023 09:30:42 PM
- Form 40-17G - Fidelity Bond [Rule 17G-1(g)] • Edgar (US Regulatory) • 11/21/2023 02:16:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 09:23:12 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/09/2023 09:34:32 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 10/25/2023 08:23:57 PM
- Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses • Edgar (US Regulatory) • 10/11/2023 08:08:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/10/2023 08:17:05 PM
- Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses • Edgar (US Regulatory) • 09/11/2023 09:22:49 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 08/31/2023 08:17:29 PM
- Form 8-A12B - Registration of securities [Section 12(b)] • Edgar (US Regulatory) • 08/17/2023 08:41:28 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM